Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Sonnet BioTherapeutics Holdings ( (SONN) ) has issued an announcement.
Sonnet BioTherapeutics Holdings, Inc., a biotech firm specializing in oncology, has met Nasdaq’s minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market. Despite this achievement, the company will be monitored for a year to maintain compliance. Sonnet focuses on developing targeted biologic drugs and is currently advancing several promising programs for cancer treatment, including collaborations with industry giants like Roche.
Learn more about SONN stock on TipRanks’ Stock Analysis page.
